Literature DB >> 14978302

Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.

Caroline M S Ekblad1, Assaf Friedler, Dmitry Veprintsev, Richard L Weinberg, Laura S Itzhaki.   

Abstract

53BP1 interacts with the DNA-binding core domain of the tumor suppressor p53 and enhances p53-mediated transcriptional activation. The p53-binding region of 53BP1 maps to the C-terminal BRCT domains, which are homologous to those found in the breast cancer protein BRCA1 and in other proteins involved in DNA repair. Here we compare the thermodynamic behavior of the BRCT domains of 53BP1 and BRCA1 and examine their ability to interact with the p53 core domain. The free energies of unfolding are of similar magnitude, although slightly higher for 53BP1-BRCT, and both populate an aggregation-prone partly folded intermediate. Interaction studies performed in vitro by analytical size-exclusion chromatography, analytical ultracentrifugation, and isothermal titration calorimetry reveal that 53BP1-BRCT interacts with p53 with a K(d) in the low micromolar range. Despite their homology with 53BP1-BRCT domains, the BRCT domains of BRCA1 did not bind p53 with any detectable affinity. In summary, although other studies have indicated that the BRCT domains of both BRCA1 and 53BP1 interact with p53 core domain, the quantitative biophysical measurements performed here indicate that only 53BP1 can bind. Although both proteins may be involved in the same DNA repair pathways, our study indicates that a direct role in p53 function is unique to 53BP1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978302      PMCID: PMC2286730          DOI: 10.1110/ps.03461404

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  23 in total

1.  Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

Authors:  Maria Rodriguez; Xiaochun Yu; Junjie Chen; Zhou Songyang
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

2.  Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

Authors:  R Scully; J Chen; R L Ochs; K Keegan; M Hoekstra; J Feunteun; D M Livingston
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

Review 3.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

4.  BRCT repeats as phosphopeptide-binding modules involved in protein targeting.

Authors:  Isaac A Manke; Drew M Lowery; Anhco Nguyen; Michael B Yaffe
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

5.  The BRCT domain is a phospho-protein binding domain.

Authors:  Xiaochun Yu; Claudia Christiano Silva Chini; Miao He; Georges Mer; Junjie Chen
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

6.  DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1.

Authors:  Oscar Fernandez-Capetillo; Hua-Tang Chen; Arkady Celeste; Irene Ward; Peter J Romanienko; Julio C Morales; Kazuhito Naka; Zhenfang Xia; R Daniel Camerini-Otero; Noboru Motoyama; Phillip B Carpenter; William M Bonner; Junjie Chen; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

7.  53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.

Authors:  Richard A DiTullio; Tamara A Mochan; Monica Venere; Jirina Bartkova; Maxwell Sehested; Jiri Bartek; Thanos D Halazonetis
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

8.  Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1.

Authors:  C M S Ekblad; H R Wilkinson; J W H Schymkowitz; F Rousseau; S M V Freund; L S Itzhaki
Journal:  J Mol Biol       Date:  2002-07-12       Impact factor: 5.469

9.  Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.

Authors:  Dean J Derbyshire; Balaku P Basu; Louise C Serpell; Woo S Joo; Takayasu Date; Kuniyoshi Iwabuchi; Aidan J Doherty
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

10.  Two cellular proteins that bind to wild-type but not mutant p53.

Authors:  K Iwabuchi; P L Bartel; B Li; R Marraccino; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

View more
  5 in total

1.  Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

Authors:  Maria Victoria E Botuyan; Yves Nominé; Xiaochun Yu; Nenad Juranic; Slobodan Macura; Junjie Chen; Georges Mer
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

2.  "Similarity trap" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains.

Authors:  Jin Liu; Yongping Pan; Buyong Ma; Ruth Nussinov
Journal:  Structure       Date:  2006-12       Impact factor: 5.006

3.  Biophysical evaluation to categorize pathogenicity of cancer-predisposing mutations identified in the BARD1 BRCT domain.

Authors:  Rajan Kumar Choudhary; M Quadir Siddiqui; Nikhil Gadewal; Nachimuthu Senthil Kumar; Ekaterina S Kuligina; Ashok K Varma
Journal:  RSC Adv       Date:  2018-10-03       Impact factor: 4.036

4.  TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs.

Authors:  Nishita Parnandi; Veronica Rendo; Gaofeng Cui; Maria Victoria Botuyan; Michaela Remisova; Huy Nguyen; Pascal Drané; Rameen Beroukhim; Matthias Altmeyer; Georges Mer; Dipanjan Chowdhury
Journal:  Mol Cell       Date:  2021-05-06       Impact factor: 19.328

5.  Tying the loose ends together in DNA double strand break repair with 53BP1.

Authors:  Melissa M Adams; Phillip B Carpenter
Journal:  Cell Div       Date:  2006-08-31       Impact factor: 5.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.